Plasminogen activator inhibitor-1 (PAI-1), a member of the serine protease inhibitor family, is elevated in obesity and insulin resistance and predicts the risk of type 2 DM [59]. This evidence concerns the gene SERPINE1 and obesity due to melanocortin 4 receptor deficiency.